Bogdan Adrian Buhas, Olivier Skowron, Martin Sié, Stéphane de Vergie, Eric Potiron, Naoufel Miaadi, Gilles Pasticier, Nam-Son Vuong, Laurent Brureau, Christophe Almeras, Vidal Azancot, Jean-Baptiste Beauval, Olivier Belas, Aude De Fourmestraux, Thomas Bommelaere, Nordine Deffar, Gilles Gourtaud, Julien Guillotreau, Truong An Nguyen, Pourya Pashootan, Grégoire Poinas, Arthur Peyrottes, Jean Rouffilange, Mathieu Roumiguié, Philippe Rouvellat, Antoine Van Hove, Caroline Pettenati, Benjamin Pradère, Alexandre de la Taille, Gaëlle Fiard, Charles Dariane, Guillaume Ploussard
{"title":"AirSeal®腹内压系统对机器人辅助根治性前列腺切除术后患者报告的结果和经验测量的影响","authors":"Bogdan Adrian Buhas, Olivier Skowron, Martin Sié, Stéphane de Vergie, Eric Potiron, Naoufel Miaadi, Gilles Pasticier, Nam-Son Vuong, Laurent Brureau, Christophe Almeras, Vidal Azancot, Jean-Baptiste Beauval, Olivier Belas, Aude De Fourmestraux, Thomas Bommelaere, Nordine Deffar, Gilles Gourtaud, Julien Guillotreau, Truong An Nguyen, Pourya Pashootan, Grégoire Poinas, Arthur Peyrottes, Jean Rouffilange, Mathieu Roumiguié, Philippe Rouvellat, Antoine Van Hove, Caroline Pettenati, Benjamin Pradère, Alexandre de la Taille, Gaëlle Fiard, Charles Dariane, Guillaume Ploussard","doi":"10.1007/s00345-025-05958-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the impact of the AirSeal<sup>®</sup> insufflation system on postoperative pain, analgesic consumption, and patient satisfaction following robot-assisted radical prostatectomy (RARP), using real-world patient-reported outcomes (PROMs) collected via a digital health platform.</p><p><strong>Methods: </strong>This retrospective multicenter study included 312 patients undergoing RARP for localized prostate cancer across 19 French centers (September 2024-June 2025). Forty-seven patients (15.1%) underwent RARP with AirSeal<sup>®</sup> (low or standard pressure) and 265 (84.9%) with conventional insufflation (standard pressure). Pain scores, measured using the Visual Analogue Scale and analgesic use were recorded daily from postoperative day (POD) 1-14 via the CE-certified Betty Coaching smartphone application. Secondary outcomes included length of stay, sick leave duration, patient satisfaction at 6 weeks, and postoperative complications.</p><p><strong>Results: </strong>Baseline characteristics were comparable between groups. Median pain scores were consistently lower with AirSeal<sup>®</sup>, with complete pain resolution by POD8 versus POD14 for conventional insufflation. By POD8, all AirSeal<sup>®</sup> patients were analgesic-free, compared to 83% at POD14 in the control group. All patients were opioid-free within 2 weeks. Hospital stay (median 1 day) and satisfaction (median score 10/10) were similar. Complication rates (10.6% vs. 6.8%, p = 0.352) and readmissions did not differ significantly.</p><p><strong>Conclusion: </strong>Use of the AirSeal<sup>®</sup> system in RARP was associated with faster pain resolution and earlier cessation of analgesics without compromising perioperative safety. Digital PROMs collection via the Betty Coaching platform offers precise recovery monitoring, reinforcing its role in enhanced recovery pathways and supporting the integration of valveless insufflation technology into minimally invasive urologic surgery.</p>","PeriodicalId":23954,"journal":{"name":"World Journal of Urology","volume":"43 1","pages":"574"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of intra-abdominal pressure with AirSeal<sup>®</sup> system on patient-reported outcomes and experience measurements after robot-assisted radical prostatectomy.\",\"authors\":\"Bogdan Adrian Buhas, Olivier Skowron, Martin Sié, Stéphane de Vergie, Eric Potiron, Naoufel Miaadi, Gilles Pasticier, Nam-Son Vuong, Laurent Brureau, Christophe Almeras, Vidal Azancot, Jean-Baptiste Beauval, Olivier Belas, Aude De Fourmestraux, Thomas Bommelaere, Nordine Deffar, Gilles Gourtaud, Julien Guillotreau, Truong An Nguyen, Pourya Pashootan, Grégoire Poinas, Arthur Peyrottes, Jean Rouffilange, Mathieu Roumiguié, Philippe Rouvellat, Antoine Van Hove, Caroline Pettenati, Benjamin Pradère, Alexandre de la Taille, Gaëlle Fiard, Charles Dariane, Guillaume Ploussard\",\"doi\":\"10.1007/s00345-025-05958-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To evaluate the impact of the AirSeal<sup>®</sup> insufflation system on postoperative pain, analgesic consumption, and patient satisfaction following robot-assisted radical prostatectomy (RARP), using real-world patient-reported outcomes (PROMs) collected via a digital health platform.</p><p><strong>Methods: </strong>This retrospective multicenter study included 312 patients undergoing RARP for localized prostate cancer across 19 French centers (September 2024-June 2025). Forty-seven patients (15.1%) underwent RARP with AirSeal<sup>®</sup> (low or standard pressure) and 265 (84.9%) with conventional insufflation (standard pressure). Pain scores, measured using the Visual Analogue Scale and analgesic use were recorded daily from postoperative day (POD) 1-14 via the CE-certified Betty Coaching smartphone application. Secondary outcomes included length of stay, sick leave duration, patient satisfaction at 6 weeks, and postoperative complications.</p><p><strong>Results: </strong>Baseline characteristics were comparable between groups. Median pain scores were consistently lower with AirSeal<sup>®</sup>, with complete pain resolution by POD8 versus POD14 for conventional insufflation. By POD8, all AirSeal<sup>®</sup> patients were analgesic-free, compared to 83% at POD14 in the control group. All patients were opioid-free within 2 weeks. Hospital stay (median 1 day) and satisfaction (median score 10/10) were similar. Complication rates (10.6% vs. 6.8%, p = 0.352) and readmissions did not differ significantly.</p><p><strong>Conclusion: </strong>Use of the AirSeal<sup>®</sup> system in RARP was associated with faster pain resolution and earlier cessation of analgesics without compromising perioperative safety. Digital PROMs collection via the Betty Coaching platform offers precise recovery monitoring, reinforcing its role in enhanced recovery pathways and supporting the integration of valveless insufflation technology into minimally invasive urologic surgery.</p>\",\"PeriodicalId\":23954,\"journal\":{\"name\":\"World Journal of Urology\",\"volume\":\"43 1\",\"pages\":\"574\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00345-025-05958-x\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00345-025-05958-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:利用数字健康平台收集的真实患者报告结果(PROMs),评估AirSeal®充气系统对机器人辅助根治性前列腺切除术(RARP)术后疼痛、镇痛药消耗和患者满意度的影响。方法:这项回顾性多中心研究纳入了法国19个中心(2024年9月至2025年6月)的312例接受RARP治疗的局限性前列腺癌患者。47例(15.1%)患者采用AirSeal®(低压或标准压力)进行RARP, 265例(84.9%)患者采用常规充气(标准压力)。通过ce认证的Betty Coaching智能手机应用程序,从术后1-14天每天记录疼痛评分,使用视觉模拟量表和止痛药使用情况。次要结局包括住院时间、病假时间、6周患者满意度和术后并发症。结果:两组间基线特征具有可比性。AirSeal®的中位疼痛评分始终较低,与传统的POD14相比,POD8可以完全缓解疼痛。到POD8时,所有AirSeal®患者均无镇痛,而对照组在POD14时为83%。所有患者2周内均无阿片类药物使用。住院时间(中位1天)和满意度(中位评分10/10)相似。并发症发生率(10.6% vs. 6.8%, p = 0.352)和再入院率无显著差异。结论:在RARP中使用AirSeal®系统可以更快地缓解疼痛,更早地停止止痛药,而不会影响围手术期的安全性。通过Betty Coaching平台收集的数字prom提供了精确的恢复监测,加强了其在增强恢复途径中的作用,并支持将无瓣膜充气技术整合到微创泌尿外科手术中。
Impact of intra-abdominal pressure with AirSeal® system on patient-reported outcomes and experience measurements after robot-assisted radical prostatectomy.
Purpose: To evaluate the impact of the AirSeal® insufflation system on postoperative pain, analgesic consumption, and patient satisfaction following robot-assisted radical prostatectomy (RARP), using real-world patient-reported outcomes (PROMs) collected via a digital health platform.
Methods: This retrospective multicenter study included 312 patients undergoing RARP for localized prostate cancer across 19 French centers (September 2024-June 2025). Forty-seven patients (15.1%) underwent RARP with AirSeal® (low or standard pressure) and 265 (84.9%) with conventional insufflation (standard pressure). Pain scores, measured using the Visual Analogue Scale and analgesic use were recorded daily from postoperative day (POD) 1-14 via the CE-certified Betty Coaching smartphone application. Secondary outcomes included length of stay, sick leave duration, patient satisfaction at 6 weeks, and postoperative complications.
Results: Baseline characteristics were comparable between groups. Median pain scores were consistently lower with AirSeal®, with complete pain resolution by POD8 versus POD14 for conventional insufflation. By POD8, all AirSeal® patients were analgesic-free, compared to 83% at POD14 in the control group. All patients were opioid-free within 2 weeks. Hospital stay (median 1 day) and satisfaction (median score 10/10) were similar. Complication rates (10.6% vs. 6.8%, p = 0.352) and readmissions did not differ significantly.
Conclusion: Use of the AirSeal® system in RARP was associated with faster pain resolution and earlier cessation of analgesics without compromising perioperative safety. Digital PROMs collection via the Betty Coaching platform offers precise recovery monitoring, reinforcing its role in enhanced recovery pathways and supporting the integration of valveless insufflation technology into minimally invasive urologic surgery.
期刊介绍:
The WORLD JOURNAL OF UROLOGY conveys regularly the essential results of urological research and their practical and clinical relevance to a broad audience of urologists in research and clinical practice. In order to guarantee a balanced program, articles are published to reflect the developments in all fields of urology on an internationally advanced level. Each issue treats a main topic in review articles of invited international experts. Free papers are unrelated articles to the main topic.